Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
| Revenue (Most Recent Fiscal Year) | $32.55M |
| Net Income (Most Recent Fiscal Year) | $-6.18M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.04 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.29 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -21.76% |
| Net Margin (Trailing 12 Months) | -22.87% |
| Return on Equity (Trailing 12 Months) | -50.87% |
| Return on Assets (Trailing 12 Months) | -27.00% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.39 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.03 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.08 |
| Inventory Turnover (Trailing 12 Months) | 3.57 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.47 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.11 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.16 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.23 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 37.80M |
| Free Float | 35.99M |
| Market Capitalization | $42.34M |
| Average Volume (Last 20 Days) | 1.90M |
| Beta (Past 60 Months) | 1.40 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.79% |
| Percentage Held By Institutions (Latest 13F Reports) | 44.99% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |